Location History:
- Palo Alto, CA (US) (2012 - 2017)
- Science City, CN (2021)
Company Filing History:
3 out of 3 
1 out of 4 
1 out of 5 
Years Active: 2012-2021
Title: Innovations and Contributions of Jin-Chen Yu
Introduction
Jin-Chen Yu is a prominent inventor based in Palo Alto, CA, known for his significant contributions to the field of biomedical research. He holds a total of 5 patents that focus on innovative treatments for various diseases. His work primarily revolves around the development of compounds and methods that target specific disease markers.
Latest Patents
One of his latest patents is titled "Compounds and methods for the treatment of TROP2 positive diseases." This invention relates to compounds that include antibodies and immunoconjugates designed to bind to TROP2 (TACSTD2). The methods outlined in this patent aim to diagnose and treat malignancies associated with TROP2. Another notable patent is "Compounds and methods for the treatment of ERB B2/NEU positive diseases." This patent discloses anti-ERB B2/NEU antibodies conjugated with maytansinoid drugs, which are intended for targeted delivery to disease tissues. The methods provided in this patent focus on treating ERB B2/NEU positive cells in cancers.
Career Highlights
Jin-Chen Yu has worked with several notable companies in the pharmaceutical industry, including Nexgenix Pharmaceuticals, Inc. and Bio-Thera Solutions, Ltd. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Throughout his career, Jin-Chen has collaborated with esteemed colleagues such as Ruihong Chen and Allan E Rubenstein. These collaborations have further enhanced his research and development efforts in the field of biomedical innovation.
Conclusion
Jin-Chen Yu's work exemplifies the impact of innovative research in the treatment of serious diseases. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.